The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Dermatofibrosarcoma


High impact information on Dermatofibrosarcoma


Chemical compound and disease context of Dermatofibrosarcoma


Biological context of Dermatofibrosarcoma


Anatomical context of Dermatofibrosarcoma


Gene context of Dermatofibrosarcoma


Analytical, diagnostic and therapeutic context of Dermatofibrosarcoma


  1. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. Fiore, M., Miceli, R., Mussi, C., Lo Vullo, S., Mariani, L., Lozza, L., Collini, P., Olmi, P., Casali, P.G., Gronchi, A. J. Clin. Oncol. (2005) [Pubmed]
  2. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans. Sheng, W.Q., Hashimoto, H., Okamoto, S., Ishida, T., Meis-Kindblom, J.M., Kindblom, L.G., Hisaoka, M. J. Pathol. (2001) [Pubmed]
  3. Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats. Reddy, J.K., Qureshi, S.A. Br. J. Cancer (1979) [Pubmed]
  4. Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Folpe, A.L., Billings, S.D., McKenney, J.K., Walsh, S.V., Nusrat, A., Weiss, S.W. Am. J. Surg. Pathol. (2002) [Pubmed]
  5. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans. Zelger, B.W., Ofner, D., Zelger, B.G. Histopathology (1995) [Pubmed]
  6. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Simon, M.P., Pedeutour, F., Sirvent, N., Grosgeorge, J., Minoletti, F., Coindre, J.M., Terrier-Lacombe, M.J., Mandahl, N., Craver, R.D., Blin, N., Sozzi, G., Turc-Carel, C., O'Brien, K.P., Kedra, D., Fransson, I., Guilbaud, C., Dumanski, J.P. Nat. Genet. (1997) [Pubmed]
  7. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. McArthur, G.A., Demetri, G.D., van Oosterom, A., Heinrich, M.C., Debiec-Rychter, M., Corless, C.L., Nikolova, Z., Dimitrijevic, S., Fletcher, J.A. J. Clin. Oncol. (2005) [Pubmed]
  8. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. Rubin, B.P., Schuetze, S.M., Eary, J.F., Norwood, T.H., Mirza, S., Conrad, E.U., Bruckner, J.D. J. Clin. Oncol. (2002) [Pubmed]
  9. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Shimizu, A., O'Brien, K.P., Sjöblom, T., Pietras, K., Buchdunger, E., Collins, V.P., Heldin, C.H., Dumanski, J.P., Ostman, A. Cancer Res. (1999) [Pubmed]
  10. Imatinib GIST keeps finding new indications: successful treatment of dermatofibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor. Sawyers, C.L. J. Clin. Oncol. (2002) [Pubmed]
  11. Mitogenic activity of dermatofibrosarcoma protuberans is mediated via an extracellular signal related kinase dependent pathway. Ihn, H., Tamaki, K. J. Invest. Dermatol. (2002) [Pubmed]
  12. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues. Wang, J., Hisaoka, M., Shimajiri, S., Morimitsu, Y., Hashimoto, H. Diagn. Mol. Pathol. (1999) [Pubmed]
  13. Giant cell fibroblastoma. New histological observations. Díaz-Cascajo, C., Borrego, L., Bastida-Iñarrea, J., Borghi, S. The American Journal of dermatopathology. (1996) [Pubmed]
  14. Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans. Takahira, T., Oda, Y., Tamiya, S., Yamamoto, H., Kawaguchi, K., Kobayashi, C., Oda, S., Iwamoto, Y., Tsuneyoshi, M. Hum. Pathol. (2004) [Pubmed]
  15. Atrophic dermatofibrosarcoma protuberans: an uncommon and misleading variant. Wu, J.K., Malik, M.M., Egan, C.A. Australas. J. Dermatol. (2004) [Pubmed]
  16. EMA+ cells in dermatofibrosarcoma protuberans. A study of 11 tumors suggesting perineurial cell differentiation. Zámecník, M., Michal, M. Ceskoslovenská patologie. (2002) [Pubmed]
  17. Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Westra, W.H., Gerald, W.L., Rosai, J. Am. J. Surg. Pathol. (1994) [Pubmed]
  18. Atrophic dermatofibroma: a case report and review of the literature. Hendi, A., Jukic, D.M., Kress, D.W., Brodland, D.G. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. (2002) [Pubmed]
  19. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oliveira, A.M., Perez-Atayde, A.R., Dal Cin, P., Gebhardt, M.C., Chen, C.J., Neff, J.R., Demetri, G.D., Rosenberg, A.E., Bridge, J.A., Fletcher, J.A. Oncogene (2005) [Pubmed]
  20. Dermatofibrosarcoma protuberans with COL1A1 (exon 18) -PDGFB (exon 2) fusion transcript. Saeki, H., Ohmatsu, H., Hoashi, T., Asano, N., Idezuki, T., Kawabata, Y., Asahina, A., Kikuchi, K., Tamaki, K. Br. J. Dermatol. (2003) [Pubmed]
  21. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. Li, N., McNiff, J., Hui, P., Manfioletti, G., Tallini, G. The American Journal of dermatopathology. (2004) [Pubmed]
  22. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Lazova, R., Moynes, R., May, D., Scott, G. Cancer (1997) [Pubmed]
  23. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Hisaoka, M., Okamoto, S., Morimitsu, Y., Tsuji, S., Hashimoto, H. Virchows Arch. (1998) [Pubmed]
  24. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. Cribier, B., Noacco, G., Peltre, B., Grosshans, E. J. Am. Acad. Dermatol. (2002) [Pubmed]
  25. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Calikoglu, E., Augsburger, E., Chavaz, P., Saurat, J.H., Kaya, G. J. Cutan. Pathol. (2003) [Pubmed]
  26. A light microscopic and immunohistochemical evaluation of scars. Kamath, N.V., Ormsby, A., Bergfeld, W.F., House, N.S. J. Cutan. Pathol. (2002) [Pubmed]
  27. Mohs micrographic surgery: established uses and emerging trends. Pennington, B.E., Leffell, D.J. Oncology (Williston Park, N.Y.) (2005) [Pubmed]
WikiGenes - Universities